Susquehanna International Group, LLP Regenxbio Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $174,134 - $238,874	16,600 Added 71.86%	39,700 $416,000
Q2 2024 Aug 15, 2024	BUY	$11.51 - $21.53 $139,271 - $260,513	12,100 Added 110.0%	23,100 $270,000
Q1 2024 May 07, 2024	SELL	$12.17 - $24.61 $59,633 - $120,589	-4,900 Reduced 30.82%	11,000 $231,000
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $204,951 - $331,038	15,900 New	15,900 $285,000
Q2 2023 Aug 11, 2023	BUY	$17.23 - $21.71 $267,065 - $336,505	15,500 Added 76.73%	35,700 $713,000
Q1 2023 May 16, 2023	BUY	$18.08 - $24.55 $365,215 - $495,910	20,200 New	20,200 $381,000
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $151,572 - $238,272	-6,800 Reduced 25.95%	19,400 $513,000
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $462,465 - $837,456	-23,900 Reduced 47.7%	26,200 $647,000
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $238,814 - $332,807	-9,700 Reduced 16.22%	50,100 $1.66 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $1.03 Million - $1.37 Million	34,000 Added 131.78%	59,800 $1.96 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $127,996 - $200,992	4,400 Added 20.56%	25,800 $1.08 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $40.48 $1.03 Million - $1.28 Million	-31,700 Reduced 59.7%	21,400 $831,000
Q1 2021 May 17, 2021	SELL	$33.61 - $49.95 $1.8 Million - $2.68 Million	-53,700 Reduced 50.28%	53,100 $1.81 Million
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $2.24 Million - $4.16 Million	84,300 Added 374.67%	106,800 $4.84 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $2.58 Million - $3.84 Million	-95,400 Reduced 80.92%	22,500 $619,000
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $177,600 - $278,016	6,400 Added 5.74%	117,900 $4.34 Million
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $817,000 - $2.06 Million	38,000 Added 51.7%	111,500 $3.61 Million
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $248,688 - $323,064	7,200 Added 10.86%	73,500 $3.01 Million
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $550,832 - $880,224	17,300 Added 35.31%	66,300 $2.36 Million
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $945,000 - $1.33 Million	22,500 Added 84.91%	49,000 $2.52 Million
Q1 2019 May 15, 2019	SELL	$40.82 - $62.45 $1.4 Million - $2.14 Million	-34,300 Reduced 56.41%	26,500 $1.52 Million
Q4 2018 Feb 14, 2019	SELL	$39.11 - $75.15 $297,236 - $571,140	-7,600 Reduced 11.11%	60,800 $2.55 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $1.52 Million - $1.92 Million	-23,400 Reduced 25.49%	68,400 $5.16 Million
Q2 2018 Aug 14, 2018	BUY	$27.2 - $74.35 $2.18 Million - $5.96 Million	80,200 Added 691.38%	91,800 $6.59 Million
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $2.25 Million - $3.51 Million	-93,600 Reduced 88.97%	11,600 $346,000
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $2.41 Million - $3.21 Million	92,700 Added 741.6%	105,200 $3.5 Million
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $225,000 - $411,875	12,500	12,500 $412,000

Others Institutions Holding RGNX

# of Institutions

197

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $416M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account